🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study Design * Randomized, double-blind, placebo-controlled, escalating si...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT01037543
Treatments Being Tested
The purpose of this study is to assess the effect of test doses of SPI-2012...
Status
Completed
Location
Arizona Center for Cancer Care
Start Date
2013-03-25
Trial ID
NCT01724866
Treatments Being Tested
The purpose of this study is to evaluate the safety and pharmacokinetics of...
Status
Recruiting
Location
New York Medical College
Start Date
2021-05-20
Trial ID
NCT04570423
Treatments Being Tested
The purpose of this study is to compare the efficacy of SPI-2012 versus peg...
Status
Completed
Location
ACRC/ Arizona Clinical Research Center Inc.
Start Date
2017-05-10
Trial ID
NCT02953340
Treatments Being Tested
The purpose of this study was to compare the efficacy of a single dose of S...
Status
Completed
Location
Arizona Center for Cancer Care
Start Date
2016-01-19
Trial ID
NCT02643420
Treatments Being Tested
* Study Design * Randomized, Double-blind, Placebo-controlled, escalatin...
Status
Completed
Location
Multiple Locations
Start Date
2009-10
Trial ID
NCT00998283
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetic (PK) profile o...
Status
Completed
Location
Research Center
Start Date
2017-05-11
Trial ID
NCT03135951
Treatments Being Tested
The purpose of this study is to compare the effect of Eflapegrastim on dura...
Status
Completed
Location
ACRC/ Arizona Clinical Research Center
Start Date
2020-03-11
Trial ID
NCT04187898
Treatments Being Tested
Patients who experienced neutropenia after receiving pegfilgrastim on day 1...
Status
Unknown
Location
Good Gang-An Hospital
Start Date
2023-11-07
Trial ID
NCT05949333
Treatments Being Tested